文献速递生殖医学妇科

性别多元成人生育力保存的趋势、观点与反思

Fertility preservation trends, perspectives, and reflections in gender diverse adults across the life course.
PubMed 文献 · Hum Reprod · 2026-01-01

该研究在Mayo Clinic跨性别与间性人专科门诊开展两阶段研究:回顾性队列纳入589例提供研究授权的TGD患者,生育力保存利用率为6.62%;并对36名参与者进行质性访谈,探讨其生育力保存决策体验与障碍。

要点

  • TGD患者生育力保存利用率低,本队列为6.62%。
  • 经济限制与保险覆盖不足是生育力保存的主要障碍。
  • 需在性别肯定医疗中结构化讨论生育力保存。

核心结论

  • TGD患者生育力保存服务利用率较低,本队列为6.62%。
  • 需要围绕生育力保存开展更结构化的沟通,并改善可及性与保险覆盖。

研究设计与样本

  • 两阶段研究:第一阶段为回顾性队列,纳入2015年1月1日至2021年7月30日Mayo Clinic TISCC提供电子健康记录研究授权的589例TGD患者。
  • 第二阶段为质性访谈,36名参与者中25名来自Mayo Clinic TISCC、11名来自JASMYN,访谈于2023年1月至6月进行。

主要发现

  • 589例患者(中位年龄28岁,范围8-78岁)中生育力保存利用率为6.62%。
  • 39例完成生育力保存,其中14例在就诊TISCC前已于其他机构接受服务,25例在Mayo Clinic内寻求生育力保存服务。
  • 睾丸患者通过精子冷冻保存完成生育力保存的可能性高于卵巢患者通过卵子冷冻保存的利用率。
  • 访谈主要主题包括:对生物学子女的渴望、围绕生育意愿规划性别医疗、关于生育力保存选项的对话、追求生育力保存的身体与心理社会障碍、对个人生育力保存决策的反思、以及对在年轻时需做生育力保存决策的反思。

临床怎么用

  • 在TGD患者寻求医学和外科性别肯定医疗时,应结构化讨论生育力保存。
  • 关注经济障碍与保险覆盖限制,通过提高可负担性可能改善生育力保存利用率。

局限性

  • 完成访谈的参与者均为自愿参加,可能存在选择偏倚和回忆偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What is the fertility preservation (FP) utilization rate among transgender and gender diverse (TGD) patients at the Transgender and Intersex Specialty Care Clinic (TISCC) within the Mayo Clinic? SUMMARY ANSWER: The rate of utilization of FP services by TGD patients at Mayo Clinic's TISCC was determined to be 6.62%. WHAT IS KNOWN ALREADY: TGD patients encounter several barriers when pursuing FP, which may contribute to a lower utilization rate of these services. These barriers include financial constraints and lack of insurance coverage, as well as societal and healthcare provider attitudes; TGD individuals face discrimination or lack of understanding, making it uncomfortable or difficult to discuss FP options. Additionally, there continues to be a lack of inclusive policies and support within healthcare systems that can further impede access to FP services for TGD individuals. STUDY DESIGN, SIZE, DURATION: The study was executed in two phases. In the first phase, a retrospective cohort study was completed with TGD patients who provided electronic health record (EHR) research authorization from Mayo Clinic's TISCC in Rochester, MN between 1 January 2015 and 30 July 2021. Search terms related to FP were used to determine the FP utilization rate among this patient population. In the second phase of the study, two sets of patients, (i) patients who were included in the cohort study in Phase 1, and (ii) members of JASMYN, a community organization specializing in care and wellness coordination for Lesbian, Gay, Bisexual, and Transgender (LGBT) teens and young adults in North Florida. Individuals were invited to participate in a qualitative interview exploring their cumulative healthcare experiences accessing gender-affirming care. Interviews were conducted from January 2023 to June 2023. Interviews examined participants' perceptions of FP options, motivations for pursuing FP, and barriers to accessing both gender and fertility care. When applicable, participants also discussed their experiences pursuing FP and reflected on their satisfaction with their fertility and family planning decisions. PARTICIPANTS/MATERIALS, SETTING, METHODS: In phase 1, a total of N = 1189 patients sought care from Mayo Clinic's TISCC in Rochester, MN. Out of these patients, N = 589 patients provided research authorization and were included in the retrospective cohort study. The study team assessed whether FP terms were mentioned in each patient's EHR, and whether patients scheduled and attended appointments with either the Department of Reproductive Endocrinology or the Department of Urology. FP search terms included sperm cryopreservation, sperm extraction, sperm aspiration, testicular tissue cryopreservation, oocyte cryopreservation, embryo cryopreservation, and ovarian tissue cryopreservation. In phase 2, N = 36 participants were interviewed, with N = 25 participants recruited from Mayo Clinic's TISCC in Rochester, MN, and N = 11 participants recruited from JASMYN in Jacksonville, FL. Participants recruited from the Mayo Clinic participated in a video-call-based interview and those enrolled from JASMYN were interviewed in person. MAIN RESULTS AND THE ROLE OF CHANCE: The study team observed a 6.62% utilization rate of FP services among N = 589 patients (median age: 28 years; age range: 8-78 years) included in the retrospective cohort study. N = 39 patients completed FP, with N = 14 receiving these services at other institutions before seeking care with the TISCC at Mayo Clinic. N = 25 patients pursued FP services within the Mayo Clinic. Patients with testes were more likely to complete FP via sperm cryopreservation when compared to the utilization of egg cryopreservation among patients with ovaries. Participants who completed an interview in Phase 2 (median age 27 years; age range: 22-80 years) reflected on their decision on whether to preserve their fertility and what factors influenced these decisions, and how their satisfaction with this decision has changed over their lifespan. The major themes reported here include the desire for biological children, planning gender care around fertility desires, conversations about FP options, physical and psychosocial barriers to pursuing FP, reflections on personal FP decisions, and reflections on having to make decisions about FP at a young age. LIMITATIONS, REASONS FOR CAUTION: All participants who completed an interview have done so voluntarily; as such, there is a possibility of selection and recall bias. WIDER IMPLICATIONS OF THE FINDINGS: Findings suggest that there is a need for more structured conversations around FP when TGD patients seek medical and surgical gender-affirming care. Accessibility, including financial barriers and limited insurance coverage, continues to limit the utilization of FP services among TGD patients. Increased affordability through insurance coverage may additionally improve FP utilization. STUDY FUNDING/COMPETING INTEREST(S): This project was funded by the Mayo Clinic Department of Obstetrics and Gynecology and the Mayo Clinic Center for Clinical and Translational Science (CCaTS), grant number UL1TR002377. This project was also supported by Clinical and Translational Science Award (CTSA) Grant Number TL1TR002380 from the National Center for Advancing Translational Sciences (NCATS). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. Felicity Enders reports grants from the National Institutes of Health and the Agency for Healthcare Research and Quality paid to her institution; speakers' fees for lectures or presentations from Mount Sinai, University of Washington, University of Minnesota, University of Rochester, Cincinnati University, the National Institutes of Health, Duke University, Wake Forest University, the Patient Centered Outcomes Research Institute, Johns Hopkins University; travel support from the Association for Clinical and Translational Science and Cold Spring Harbor Laboratory; and an unpaid leadership role on the Board of Directors of the Association for Clinical and Translational Science. All other authors declare no conflicts of interest. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Dsouza KN, Orellana MA, Vasilev DV, et al. Fertility preservation trends, perspectives, and reflections in gender diverse adults across the life course. Hum Reprod. 2026. PMID: 42035457. doi:10.1093/humrep/deag070

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。